RecruitingNCT06787625

Development of Organoids From Primary Colorectal Tumors and Synchronous Liver Metastases

Pilot Feasibility Study for the Development of Organoids From Primary Colorectal Tumors and Synchronous Liver Metastases


Sponsor

Regina Elena Cancer Institute

Enrollment

10 participants

Start Date

May 25, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Pilot feasibility study for the development of organoids from primary colorectal tumors and synchronous liver metastases, to prepare organoids from primary colorectal tumors and synchronous liver metastases. The organoids will allow us to study the function of genes targeted by the activity of the NF-Y/p53 complex.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting tumor tissue samples from patients with colorectal cancer that has spread to the liver, in order to grow miniature versions of their tumors in a lab (called organoids). These lab-grown tumor models help researchers understand why some treatments work for some patients but not others. **You may be eligible if...** - You are over 18 years old - You have been diagnosed with colorectal cancer (colon or rectal cancer) that has spread to the liver - You are scheduled to have surgery for your colorectal cancer and liver metastasis - You are willing and able to sign an informed consent form **You may NOT be eligible if...** - You do not meet the standard surgical criteria for the procedure (the same rules that apply to the surgery also apply to this study) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

"Regina Elena" National Cancer Institute

Rome, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06787625


Related Trials